Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2003 Aug;79(4):301–306. doi: 10.1136/sti.79.4.301

A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection

M Balogun 1, M Ramsay 1, J Parry 1, L Donovan 1, N Andrews 1, J Newham 1, C McGarrigle 1, K Harris 1, C Teo 1
PMCID: PMC1744706  PMID: 12902580

Abstract

Objective: To determine the prevalence and genetic diversity of hepatitis C virus in genitourinary medicine clinic attenders and to assess the extent of sexual transmission of the virus.

Methods: A cross sectional, unlinked, anonymous survey in 14 genitourinary medicine clinics situated in England, Wales, and Northern Ireland. Serum specimens from genitourinary medicine clinic attenders, retained as part of the Unlinked Anonymous Prevalence Monitoring Programme (UAPMP) serum archive, were tested in small pools, for the presence of antibody to hepatitis C virus (anti-HCV). The main outcome measures were prevalence of antibodies to hepatitis C virus and identification of hepatitis C virus genotypes.

Results: Testing of 17 586 specimens from 1995 showed an adjusted prevalence of anti-HCV in genitourinary medicine clinic attenders of 1.03% (95% CI: 0.89 to 1.16) overall and 0.65% (95% CI: 0.51 to 0.78) among those who did not report injecting drug use. Prevalence in injecting drug users attending genitourinary medicine clinics was 36.9% in both 1995 and 1996. Heterosexual injecting drug users had a higher prevalence of anti-HCV than homosexual/bisexual injectors. The most common hepatitis C genotypes were types 3a and 1a. There was a high degree of concordance between genotype and serotype.

Conclusions: The low prevalence of anti-HCV in genitourinary medicine clinic attenders who deny injecting drugs suggests that the majority of hepatitis C infections have been acquired in adult life, mostly by injecting drug use, and that the hepatitis C virus is rarely transmitted sexually. The use of needle exchanges may explain the relatively low prevalence observed in the injecting drug users.

Full Text

The Full Text of this article is available as a PDF (133.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balogun M. A., Ramsay M. E., Parry J. V., Donovan L., Andrews N. J., Newham J. A., Cliffe S., Harris K. A., Teo C. G. The prevalence and genetic diversity of hepatitis C infection in antenatal clinic attenders in two regions of England. Epidemiol Infect. 2000 Dec;125(3):705–712. doi: 10.1017/s0950268800004696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bolumar F., Hernandez-Aguado I., Ferrer L., Ruiz I., Aviño M. J., Rebagliato M. Prevalence of antibiotics to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990-1992. Int J Epidemiol. 1996 Feb;25(1):204–209. doi: 10.1093/ije/25.1.204. [DOI] [PubMed] [Google Scholar]
  3. Brackmann S. A., Gerritzen A., Oldenburg J., Brackmann H. H., Schneweis K. E. Search for intrafamilial transmission of hepatitis C virus in hemophilia patients. Blood. 1993 Feb 15;81(4):1077–1082. [PubMed] [Google Scholar]
  4. Brettler D. B., Mannucci P. M., Gringeri A., Rasko J. E., Forsberg A. D., Rumi M. G., Garsia R. J., Rickard K. A., Colombo M. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood. 1992 Jul 15;80(2):540–543. [PubMed] [Google Scholar]
  5. Castelain S., Zawadzki P., Khorsi H., Darchis J. P., Capron D., Sueur J. M., Eb F., Duverlie G. Comparison of hepatitis C virus serotyping and genotyping in French patients. Clin Diagn Virol. 1997 Feb;7(3):159–165. doi: 10.1016/s0928-0197(96)00266-8. [DOI] [PubMed] [Google Scholar]
  6. Daikos G. L., Lai S., Fischl M. A. Hepatitis C virus infection in a sexually active inner city population. The potential for heterosexual transmission. Infection. 1994 Mar-Apr;22(2):72–76. doi: 10.1007/BF01739007. [DOI] [PubMed] [Google Scholar]
  7. Donahue J. G., Nelson K. E., Muñoz A., Vlahov D., Rennie L. L., Taylor E. L., Saah A. J., Cohn S., Odaka N. J., Farzadegan H. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1991 Nov 15;134(10):1206–1211. doi: 10.1093/oxfordjournals.aje.a116023. [DOI] [PubMed] [Google Scholar]
  8. Evans B. A., McCormack S. M., Kell P. D., Parry J. V., Bond R. A., MacRae K. D. Trends in female sexual behaviour and sexually transmitted diseases in London, 1982-1992. Genitourin Med. 1995 Oct;71(5):286–290. doi: 10.1136/sti.71.5.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Girardi E., Zaccarelli M., Tossini G., Puro V., Narciso P., Visco G. Hepatitis C virus infection in intravenous drug users: prevalence and risk factors. Scand J Infect Dis. 1990;22(6):751–752. doi: 10.3109/00365549009027133. [DOI] [PubMed] [Google Scholar]
  10. Goldberg D., Cameron S., Sharp G., Burns S., Scott G., Molyneaux P., Scoular A., Downie A., Taylor A. Hepatitis C virus among genitourinary clinic attenders in Scotland: unlinked anonymous testing. Int J STD AIDS. 2001 Jan;12(1):17–21. [PubMed] [Google Scholar]
  11. Halfon P., Ouzan D., Khiri H., Feryn J. M. Serotyping and genotyping of hepatitis C virus (HCV) strains in chronic HCV infection. Commission Hepatologie du CREGG. Club de Reflexion des Cabinets de Groupes en GastroEnterologie. J Med Virol. 1997 Aug;52(4):391–395. doi: 10.1002/(sici)1096-9071(199708)52:4<391::aid-jmv8>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  12. Hallam N. F., Fletcher M. L., Read S. J., Majid A. M., Kurtz J. B., Rizza C. R. Low risk of sexual transmission of hepatitis C virus. J Med Virol. 1993 Jul;40(3):251–253. doi: 10.1002/jmv.1890400315. [DOI] [PubMed] [Google Scholar]
  13. Harris K. A., Gilham C., Mortimer P. P., Teo C. G. The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. J Med Virol. 1999 Jun;58(2):127–131. doi: 10.1002/(sici)1096-9071(199906)58:2<127::aid-jmv5>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  14. MacDonald M., Crofts N., Kaldor J. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol Rev. 1996;18(2):137–148. doi: 10.1093/oxfordjournals.epirev.a017921. [DOI] [PubMed] [Google Scholar]
  15. Melbye M., Biggar R. J., Wantzin P., Krogsgaard K., Ebbesen P., Becker N. G. Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men. BMJ. 1990 Jul 28;301(6745):210–212. doi: 10.1136/bmj.301.6745.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nakashima K., Kashiwagi S., Hayashi J., Noguchi A., Hirata M., Kajiyama W., Urabe K., Minami K., Maeda Y. Sexual transmission of hepatitis C virus among female prostitutes and patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am J Epidemiol. 1992 Nov 1;136(9):1132–1137. doi: 10.1093/oxfordjournals.aje.a116579. [DOI] [PubMed] [Google Scholar]
  17. Nicoll A., Gill O. N., Peckham C. S., Ades A. E., Parry J., Mortimer P., Goldberg D., Noone A., Bennett D., Catchpole M. The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom. Int J Epidemiol. 2000 Feb;29(1):1–10. doi: 10.1093/ije/29.1.1. [DOI] [PubMed] [Google Scholar]
  18. Parry J. V., Mahoney A., Mortimer P. P. Are seroepidemiological surveys for human immunodeficiency virus infection based on tests on pools of serum specimens accurate and cost-effective? Clin Diagn Virol. 1993 Aug;1(3):167–178. doi: 10.1016/0928-0197(93)90011-s. [DOI] [PubMed] [Google Scholar]
  19. Ramsay M. E., Balogun M. A., Collins M., Balraj V. Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996. Commun Dis Public Health. 1998 Jun;1(2):89–94. [PubMed] [Google Scholar]
  20. Silini E., Bono F., Cividini A., Cerino A., Maccabruni A., Tinelli C., Bruno S., Bellobuono A., Mondelli M. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol. 1995 Jun;22(6):691–695. doi: 10.1016/0168-8278(95)80225-8. [DOI] [PubMed] [Google Scholar]
  21. Skidmore S. J., Collingham K. E., Drake S. M. Brief report: sexual transmission of hepatitis C. J Med Virol. 1994 Mar;42(3):247–248. doi: 10.1002/jmv.1890420308. [DOI] [PubMed] [Google Scholar]
  22. Tedder R. S., Gilson R. J., Briggs M., Loveday C., Cameron C. H., Garson J. A., Kelly G. E., Weller I. V. Hepatitis C virus: evidence for sexual transmission. BMJ. 1991 Jun 1;302(6788):1299–1302. doi: 10.1136/bmj.302.6788.1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Thomas D. L., Cannon R. O., Shapiro C. N., Hook E. W., 3rd, Alter M. J., Quinn T. C. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis. 1994 May;169(5):990–995. doi: 10.1093/infdis/169.5.990. [DOI] [PubMed] [Google Scholar]
  24. Tor J., Llibre J. M., Carbonell M., Muga R., Ribera A., Soriano V., Clotet B., Sabriá M., Foz M. Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. BMJ. 1990 Nov 17;301(6761):1130–1133. doi: 10.1136/bmj.301.6761.1130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Van Ameijden E. J., Van den Hoek J. A., Mientjes G. H., Coutinho R. A. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol. 1993 May;9(3):255–262. doi: 10.1007/BF00146260. [DOI] [PubMed] [Google Scholar]
  26. Villano S. A., Vlahov D., Nelson K. E., Lyles C. M., Cohn S., Thomas D. L. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol. 1997 Dec;35(12):3274–3277. doi: 10.1128/jcm.35.12.3274-3277.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ward H., Day S., Weber J. Risky business: health and safety in the sex industry over a 9 year period. Sex Transm Infect. 1999 Oct;75(5):340–343. doi: 10.1136/sti.75.5.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Watson J. P., Brind A. M., Chapman C. E., Bates C. L., Gould F. K., Johnson S. J., Burt A. D., Ferguson J., Simmonds P., Bassendine M. F. Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut. 1996 Feb;38(2):269–276. doi: 10.1136/gut.38.2.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Weinstock H. S., Bolan G., Reingold A. L., Polish L. B. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA. 1993 Jan 20;269(3):392–394. [PubMed] [Google Scholar]
  30. Zylberberg H., Thiers V., Lagorce D., Squadrito G., Leone F., Berthelot P., Bréchot C., Pol S. Epidemiological and virological analysis of couples infected with hepatitis C virus. Gut. 1999 Jul;45(1):112–116. doi: 10.1136/gut.45.1.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. van Beek I., Buckley R., Stewart M., MacDonald M., Kaldor J. Risk factors for hepatitis C virus infection among injecting drug users in Sydney. Genitourin Med. 1994 Oct;70(5):321–324. doi: 10.1136/sti.70.5.321. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES